SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-339410
Filing Date
2014-09-12
Accepted
2014-09-11 19:27:32
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d784895d10q.htm 10-Q 666836
2 EX-31.1 d784895dex311.htm EX-31.1 8016
3 EX-31.2 d784895dex312.htm EX-31.2 7846
4 EX-32.1 d784895dex321.htm EX-32.1 4456
  Complete submission text file 0001193125-14-339410.txt   5270642

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aavl-20140630.xml EX-101.INS 662087
6 XBRL TAXONOMY EXTENSION SCHEMA aavl-20140630.xsd EX-101.SCH 51388
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aavl-20140630_cal.xml EX-101.CAL 57111
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aavl-20140630_def.xml EX-101.DEF 236120
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aavl-20140630_lab.xml EX-101.LAB 429948
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aavl-20140630_pre.xml EX-101.PRE 341628
Mailing Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025 650-272-6269
Avalanche Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36579 | Film No.: 141099256
SIC: 2836 Biological Products, (No Diagnostic Substances)